Research Project
Grant-in-Aid for Challenging Exploratory Research
A T cell clone reactive with rat vascular endothelial cells (REC) was established from the rat model of medium-to-small vessel vasculitis and named VASC-1. Intravenous injection of VASC-1 induced small vessel vasculitis (SVV) in normal recipients. After interaction with REC, several cytokines were produced from VASC-1, which was inhibited by blocking of CD1d on the REC surface. The collective findings indicated VASC-1 as an NKT cell clone. NKT cells are classified into type I and II. Type I NKT cells are characterized by expression of semi-invariant TCRs and potential to bind to marine sponge-derived alpha-galactosylceramide (a-GalCer) loaded on CD1d; whereas, type II NKT cells do not manifest the characteristics. VASC-1 exhibited a usage of TCR other than the type I invariant TCR and did not bind to a-GalCer-loaded CD1d; therefore, it was regarded as a type II NKT cell clone. These evidences suggested that REC-reactive type II NKT cells could be involved in the pathogenesis of SVV.
All 2014 2013 2012 2011 Other
All Journal Article (23 results) (of which Peer Reviewed: 19 results, Open Access: 2 results) Presentation (32 results) (of which Invited: 1 results) Remarks (8 results)
Journal of the American Society of Nephrology
Volume: Epub Issue: 5 Pages: 990-997
10.1681/asn.2013060606
Eur J Immunol
Volume: 44 Issue: 4 Pages: 1005-1015
10.1002/eji.201343434
Clin Exp Rheumatol
Volume: 32(1) Pages: 149-150
120005397871
http://www.clinexprheumatol.org/pubmed/find-pii.asp?pii=24321560
Volume: 32 Pages: 149-150
J Dermatol
Volume: 40 Issue: 12 Pages: 955-961
10.1111/1346-8138.12303
Clin Exp Nephrol
Volume: 17 Issue: 5 Pages: 631-633
10.1007/s10157-012-0738-8
120005372301
Clin Dev Immunol
Volume: 2013 Pages: 345745-345745
10.1155/2013/345745
Rheumatology
Volume: 52 Issue: 9 Pages: 1592-1598
10.1093/rheumatology/ket159
PLOS ONE
Volume: 8 Issue: 5 Pages: e63182-e63182
10.1371/journal.pone.0063182
Acta Derm Venereol
Volume: 93(1) Issue: 1 Pages: 70-73
10.2340/00015555-1418
分子リウマチ治療
Volume: 6(4) Pages: 209-213
Volume: 6(2) Pages: 82-86
日本臨床71増刊号「血管炎」
Pages: 244-249
Pages: 502-505
Lab Invest.
Volume: 93 Issue: 1 Pages: 72-80
10.1038/labinvest.2012.153
Arthritis Rheum
Volume: 64(11) Issue: 11 Pages: 3779-3787
10.1002/art.34619
Front Immunol
Volume: 3 Pages: 333-333
10.3389/fimmu.2012.00333
120005372303
Annals of Vascular Diseases
Volume: 5 Issue: 3 Pages: 296-299
10.3400/avd.ra.12.00063
130004487963
Am.J.Pathol.
Volume: 180 Issue: 3 Pages: 963-972
10.1016/j.ajpath.2011.11.012
PLoS ONE
Volume: 7(7) Issue: 7 Pages: e41154-e41154
10.1371/journal.pone.0041154
120004419373
PLoS ONE7
Volume: (9) Issue: 9 Pages: e44113-e44113
10.1371/journal.pone.0044113
Volume: 7(12) Issue: 12 Pages: e52918-e52918
10.1371/journal.pone.0052918
120005183187
Mod Rheumatol
Volume: (Epub ahead of print) Issue: 3 Pages: 394-404
10.1007/s10165-011-0525-5
10030782228
http://hdl.handle.net/2115/54623
http://hdl.handle.net/2115/54630
http://hdl.handle.net/2115/54674
http://hdl.handle.net/2115/54864